These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12324849)

  • 1. Impurity profiling of seized MDMA tablets by capillary gas chromatography.
    Palhol F; Boyer S; Naulet N; Chabrillat M
    Anal Bioanal Chem; 2002 Sep; 374(2):274-81. PubMed ID: 12324849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
    Cheng WC; Poon NL; Chan MF
    J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase extraction for profiling of ecstasy tablets.
    Rashed AM; Anderson RA; King LA
    J Forensic Sci; 2000 Mar; 45(2):413-7. PubMed ID: 10782963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol.
    Heather E; Shimmon R; McDonagh AM
    Forensic Sci Int; 2015 Mar; 248():140-7. PubMed ID: 25617761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
    Kalasinsky KS; Hugel J; Kish SJ
    J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A turn-on fluorogenic probe for detection of MDMA from ecstasy tablets.
    Moreno D; Díaz de Greñu B; García B; Ibeas S; Torroba T
    Chem Commun (Camb); 2012 Mar; 48(24):2994-6. PubMed ID: 22314849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purity and adulterant analysis of some recent drug seizures in Italy.
    Pichini S; Busardò FP; Gregori A; Berretta P; Gentili S; Pacifici R
    Drug Test Anal; 2017 Mar; 9(3):485-490. PubMed ID: 27860443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variability of ecstasy tablets composition in Brazil.
    Togni LR; Lanaro R; Resende RR; Costa JL
    J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contribution to the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets.
    Gimeno P; Besacier F; Chaudron-Thozet H; Girard J; Lamotte A
    Forensic Sci Int; 2002 Jun; 127(1-2):1-44. PubMed ID: 12098525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in The Netherlands.
    van Deursen MM; Lock ER; Poortman-van der Meere AJ
    Sci Justice; 2006; 46(3):135-52. PubMed ID: 17388242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.
    Deconinck E; Van Campenhout R; Aouadi C; Canfyn M; Bothy JL; Gremeaux L; Blanckaert P; Courselle P
    Talanta; 2019 Apr; 195():142-151. PubMed ID: 30625524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
    Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
    Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingerprinting of 3, 4-methylenedioxymethamphetamine markers by desorption/ionization on porous silicon.
    Kraj A; Swist M; Strugała A; Parczewski A; Silberring J
    Eur J Mass Spectrom (Chichester); 2006; 12(4):253-9. PubMed ID: 17057282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis and characterisation of MDMA derived from a catalytic oxidation of material isolated from black pepper reveals potential route specific impurities.
    Plummer CM; Breadon TW; Pearson JR; Jones OAH
    Sci Justice; 2016 May; 56(3):223-230. PubMed ID: 27162021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).
    Carter JF; Titterton aE; Murray M; Sleeman R
    Analyst; 2002 Jun; 127(6):830-3. PubMed ID: 12146919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15N isotopic analyses: a powerful tool to establish links between seized 3,4-methylenedioxymethamphetamine (MDMA) tablets.
    Palhol F; Lamoureux C; Naulet N
    Anal Bioanal Chem; 2003 Jun; 376(4):486-90. PubMed ID: 12819848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mCPP: an undesired addition to the ecstasy market.
    Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
    J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC on the dance floor.
    Meyer V
    Anal Chem; 2000 Dec; 72(23):735A-736A. PubMed ID: 11128956
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004.
    Giraudon I; Bello PY
    Subst Use Misuse; 2007; 42(10):1567-78. PubMed ID: 17918027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography-mass spectrometry.
    Cheng JY; Chan MF; Chan TW; Hung MY
    Forensic Sci Int; 2006 Oct; 162(1-3):87-94. PubMed ID: 16860955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.